Infinity Pharmaceuticals Inc (INFI) Insider Trading
- $98,338,746.12
- $31,404,083.42
- Sept. 12, 2023
- Value Fund L P Biotechnology
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 12, 2023 | Director | 410,196 | $0.07 | Sell | $28,713.72 | |
Jan. 22, 2021 | Major Shareholder | 5,848,520 | $4.14 | Sell | $24,212,872.80 | |
Dec. 13, 2018 | Major Shareholder | 175,000 | $1.20 | Buy | $210,000.00 | |
Nov. 28, 2018 | Major Shareholder | 100,000 | $1.30 | Buy | $130,000.00 | |
Nov. 21, 2018 | Major Shareholder | 1,469,826 | $1.37 | Buy | $2,013,661.62 | |
Nov. 19, 2018 | Major Shareholder | 1,465,126 | $1.37 | Buy | $2,007,222.62 | |
Nov. 15, 2018 | Major Shareholder | 91,474 | $1.35 | Buy | $123,489.90 | |
Nov. 13, 2018 | Major Shareholder | 604,208 | $1.35 | Buy | $815,680.80 | |
Oct. 1, 2018 | CEO | 5,000 | $2.82 | Sell | $14,100.00 | |
Aug. 15, 2018 | Insider | 8,180 | $2.01 | Sell | $16,441.80 | |
June 22, 2018 | Insider | 14,313 | $2.00 | Sell | $28,626.00 | |
June 21, 2018 | Major Shareholder | 425,531 | $1.65 | Buy | $702,126.15 | |
June 19, 2018 | Major Shareholder | 3,516,560 | $1.65 | Buy | $5,802,324.00 | |
April 10, 2018 | Major Shareholder | 1,510,000 | $1.97 | Buy | $2,974,700.00 | |
March 5, 2018 | CEO | 5,000 | $2.78 | Sell | $13,900.00 | |
Dec. 6, 2017 | President | 500,000 | $1.81 | Buy | $905,000.00 | |
Oct. 4, 2017 | Insider | 1,600,046 | $1.26 | Buy | $2,016,057.96 | |
March 17, 2017 | Director | 6,250 | $3.48 | Sell | $21,750.00 | |
Jan. 3, 2017 | Major Shareholder | 4,379 | $1.34 | Buy | $5,867.86 | |
Dec. 30, 2016 | Major Shareholder | 742,401 | $1.34 | Buy | $994,817.34 | |
Dec. 20, 2016 | Major Shareholder | 654,921 | $1.31 | Buy | $857,946.51 | |
Dec. 13, 2016 | Insider | 75,000 | $1.28 | Sell | $96,000.00 | |
Dec. 12, 2016 | Insider | 25,009 | $1.30 | Sell | $32,511.70 | |
Dec. 2, 2016 | Major Shareholder | 201,394 | $1.19 | Buy | $239,658.86 | |
June 25, 2015 | CEO | 5,000 | $10.93 | Sell | $54,650.00 | |
June 15, 2015 | Insider | 4,737 | $10.97 | Sell | $51,964.89 | |
May 27, 2015 | CEO | 10,000 | $12.81 | Sell | $128,100.00 | |
May 14, 2015 | CEO | 10,000 | $12.18 | Sell | $121,800.00 | |
March 16, 2015 | CEO | 20,000 | $16.00 | Sell | $320,000.00 | |
Jan. 29, 2015 | CEO | 20,000 | $14.83 | Sell | $296,600.00 | |
Dec. 15, 2014 | Insider | 4,737 | $16.32 | Sell | $77,307.84 | |
Nov. 26, 2014 | Insider | 4,736 | $15.00 | Sell | $71,040.00 | |
Sept. 30, 2014 | Director | 112,451 | $13.56 | Sell | $1,524,835.56 | |
Sept. 3, 2014 | Insider | 9,472 | $15.39 | Sell | $145,774.08 | |
Nov. 27, 2013 | Director | 163,864 | $14.82 | Sell | $2,428,464.48 | |
Sept. 13, 2013 | CEO | 45,000 | $20.72 | Sell | $932,400.00 | |
June 20, 2013 | Insider | 23,150 | $18.53 | Sell | $428,969.50 | |
Nov. 26, 2012 | Insider | 13,885 | $25.73 | Sell | $357,261.05 | |
Sept. 7, 2012 | Major Shareholder | 5,416,565 | $14.50 | Buy | $78,540,192.50 |
Insiders are both buying and selling Infinity Pharmaceuticals Inc stock.
The insider traders at Infinity Pharmaceuticals Inc are: Value Fund L P Biotechnology, Adelene Q Perkins, Bvf Partners L P/Il, Vito J Palombella, Sujay Kango, Jeffery Kutok, Anthony B Evnin, Co Beacon, Adelene Q. Perkins, Christopher M Lindblom, Adelene Perkins, Lawrence E Bloch, and Michael C Venuti
The most active insider trader at Infinity Pharmaceuticals Inc is Value Fund L P Biotechnology with 9 trades.
Bvf Partners L P/Il has sold the most Infinity Pharmaceuticals Inc stock with a total value of $48,425,745.60.
Co Beacon has bought the most Infinity Pharmaceuticals Inc stock with a total value of $157,080,385.00.
The most recent insider trade for Infinity Pharmaceuticals Inc was on Sept. 12, 2023.
The single biggest insider buy for Infinity Pharmaceuticals Inc was from Co Beacon with a total value of $78,540,192.50 on Sept. 7, 2012.
The single biggest insider sell for Infinity Pharmaceuticals Inc was from Bvf Partners L P/Il with a total value of $24,212,872.80 on Jan. 22, 2021.